Upcoming Events

Tissue Engineered Medical Products: Springboard from the Lab to Patients

Wednesday, March 29, 2023 (1:00 PM - 2:00 PM) (EDT)


Join MPR Associates, EpiBone, and Orgenesis (formerly TGI) for a fireside chat about the common roadblocks in commercializing Tissue Engineered Medical Products (TEMPs) and how to remove them.  Challenges for commercialization include: chain-of-custody, validating production processes as volume increases, and process automation and closure.  Panelists will share insights into how their own challenges were overcome.



Maria Pascale

Maria Pascale is a Senior Engineer at MPR Associates, an engineering consulting company providing strategy, project execution, and product development services to medical device, pharmaceutical, and other health and life science firms.

Pascale is experienced in mechanical design, materials selection and design, systems design, and technical integration on projects ranging from the development of multi-million-dollar devices to creative minimalist devices designed for low profile delivery while maximizing therapeutic effect.  Pascale applies this experience in the emerging tissue engineered medical product (TEMP) market, helping small and large companies transition their impactful products from the laboratory to the clinic and hospital.  To increase her impact as a catalyst for these transitions, Pascale is a member of the Leadership Advisory Council of the Advanced Regenerative Manufacturing Institute (ARMI).


Sarindr “Ik” Bhumriatana, PhD

Sarindr “Ik” Bhumriatana, PhD is the Chief Scientific Officer and Co-Founder of EpiBone Inc, a clinical stage company developing tissue engineered medical product for skeletal reconstruction. He is the inventor of EpiBone’s core technology on MSC processing and tissue maturation bioreactor. He published more than 20 scientific publications, 5 book chapters, and 8 IP families.

Ryan Downs

Ryan Downs is the Vice President of Health & Life Science at MPR Associates an engineering services and consulting firm focused on developing technology, capturing opportunity, and overcoming challenges for our partners.  Ryan focuses on aligning a client’s technology, product or process with their business model to enable success.

Paul Kosnik

VP of Clinical Development at Orgenesis. Formerly the VP of Engineering at Tissue Genesis, Inc.
Wednesday, March 29, 2023 (1:00 PM - 2:00 PM) (EDT)
Powered By GrowthZone